Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2695 |
|
Actual shortage: | 246 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2440 (91%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
26 (10%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-EXEMESTANE | 25MG | TABLET | Resolved | 2023-02-02 | 2023-04-28 | 183416 |
TEVA-EXEMESTANE | 25MG | TABLET | Resolved | 2023-06-08 | 2023-10-04 | 194175 |
TEVA-EXEMESTANE | 25MG | TABLET | Resolved | 2023-06-19 | 2023-07-05 | 195569 |
TEVA-EZETIMIBE | 10MG | TABLET | Resolved | 2017-05-10 | 2017-09-19 | 9796 |
TEVA-EZETIMIBE | 10MG | TABLET | Resolved | 2017-08-01 | 2017-11-06 | 17890 |
TEVA-EZETIMIBE | 10MG | TABLET | Resolved | 2017-08-21 | 2017-09-19 | 19941 |
TEVA-EZETIMIBE | 10MG | TABLET | Resolved | 2020-06-04 | 2020-06-11 | 116666 |
TEVA-EZETIMIBE | 10MG | TABLET | Resolved | 2020-09-03 | 2021-01-07 | 123726 |
TEVA-EZETIMIBE | 10MG | TABLET | Resolved | 2021-02-18 | 2021-03-11 | 134331 |
TEVA-EZETIMIBE | 10MG | TABLET | Resolved | 2021-03-25 | 2021-04-01 | 136338 |
TEVA-EZETIMIBE | 10MG | TABLET | Resolved | 2021-05-13 | 2021-09-02 | 139300 |
TEVA-EZETIMIBE | 10MG | TABLET | Resolved | 2021-06-17 | 2021-07-22 | 141122 |
TEVA-EZETIMIBE | 10MG | TABLET | Resolved | 2021-06-17 | 2021-07-15 | 141128 |
TEVA-EZETIMIBE | 10MG | TABLET | Resolved | 2022-06-09 | 2022-07-26 | 162291 |
TEVA-EZETIMIBE | 10MG | TABLET | Resolved | 2023-11-03 | 2024-01-25 | 209125 |
TEVA-EZETIMIBE | 10MG | TABLET | Resolved | 2023-11-03 | 2023-11-23 | 209130 |
TEVA-EZETIMIBE | 10MG | TABLET | Resolved | 2023-11-03 | 2024-01-25 | 209133 |
TEVA-EZETIMIBE | 10MG | TABLET | Actual shortage | 2024-02-08 | 2024-02-08 | 218980 |
TEVA-EZETIMIBE | 10MG | TABLET | Resolved | 2024-03-18 | 2024-05-30 | 222569 |
TEVA-EZETIMIBE | 10MG | TABLET | Resolved | 2024-03-28 | 2024-05-30 | 223850 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
NOVAMOXIN | 125MG | TABLET (CHEWABLE) | Discontinued | 2019-10-25 | 2019-10-26 | 97251 |
NOVAMOXIN | 250MG | CAPSULE | Discontinued | 2020-01-24 | 2020-01-24 | 104289 |
NOVASEN | 325MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63955 |
NOVASEN | 325MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63959 |
NOVASEN | 650MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63964 |
NOVO-PROFEN | 400MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64920 |
NOVO-PROFEN | 200MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81310 |
PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.375G 3G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210191 |
PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.5G 4G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210194 |
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64589 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64592 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64615 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64623 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64626 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-19 | 2018-10-19 | 64852 | ||
RATIO-FENOFIBRATE MC | 200MG | CAPSULE | Discontinued | 2018-10-12 | 2018-10-12 | 63943 |
RATIO-FENOFIBRATE MC | 200MG | CAPSULE | Discontinued | 2018-10-19 | 2018-10-19 | 64891 |
TEVA-LENOLTEC NO. 1 | 300MG 8MG 15MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81362 |
RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64595 | ||
RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64598 |